SLNSW-Regulatory T (Treg) cells in cancer: Can Treg cel...-TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

Full title: Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

Author/creator: Ohue, Yoshihiro, Nishikawa, Hiroyoshi.

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

Language: English

Formats: Articles

Publishers: England: Wiley Subscription Services, Inc

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

    Record identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

    Share

    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

    Full title

    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

    Author / Creator

    Ohue, Yoshihiro ; Nishikawa, Hiroyoshi

    Publisher

    England: Wiley Subscription Services, Inc

    Journal title

    Cancer science, 2019, Vol.110 (7), p.2080-2089

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adenosine Animals Antigens Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Antineoplastic Agents, Immunological - pharmacology Antineoplastic Agents, Immunological - therapeutic use Antitumor activity Autoantigens Autoimmune diseases Autoimmunity Cancer Cancer immunotherapy CCL17 protein CCR8 protein CD25 antigen CD80 antigen CD86 antigen Cell survival Chemokine receptors Chemokines CTLA-4 Antigen - metabolism CXCR3 protein Cytokines Cytokines - metabolism Cytotoxicity Dendritic cells Development and progression Effector cells Health aspects Homeostasis Humans Immune checkpoint immune suppression Immunoregulation Immunotherapy Immunotherapy - methods Interleukin-2 - metabolism Interleukin-2 Receptor alpha Subunit - metabolism Lymphocytes Lymphocytes T Metabolism Metabolites Metastases Mice Neoplasms - drug therapy Neoplasms - immunology Patients Precision medicine Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Review Small Molecule Libraries - pharmacology Small Molecule Libraries - therapeutic use T cells T-Lymphocytes, Regulatory - drug effects T-Lymphocytes, Regulatory - immunology Therapeutic applications tolerance Treg tumor Tumor necrosis factor-TNF Vascular endothelial growth factor

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6609813

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections